Development and Validation of an Affinity Chromatography-Protein G Method for IgG Quantification.

about

High-capacity protein A affinity chromatography for the fast quantification of antibodies: Two-wavelength detection expands linear range.

P2860

Q48249790-E7085843-0D74-4F44-A93F-DE48F0FF1600

P2860

Development and Validation of an Affinity Chromatography-Protein G Method for IgG Quantification.

Item

http://www.wikidata.org/entity/Q42158271

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Development and Validation of ...... Method for IgG Quantification.

@en

Development and Validation of ...... Method for IgG Quantification.

@nl

type

Item

label

Development and Validation of ...... Method for IgG Quantification.

@en

Development and Validation of ...... Method for IgG Quantification.

@nl

prefLabel

Development and Validation of ...... Method for IgG Quantification.

@en

Development and Validation of ...... Method for IgG Quantification.

@nl

P1476

Development and Validation of ...... Method for IgG Quantification.

@en

P2093

Lesly Paradina Fernández

http://www.w3.org/2001/XMLSchema#string

Lisel Viña

http://www.w3.org/2001/XMLSchema#string

Loany Calvo

http://www.w3.org/2001/XMLSchema#string

P2860

Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation

Guidance for robustness/ruggedness tests in method validation

Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells.

Characterization of a recombinant monoclonal antibody by mass spectrometry combined with liquid chromatography.

Structural characterization of N-linked oligosaccharides on monoclonal antibody Nimotuzumab through process development.

Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity.

Nimotuzumab in pediatric glioma.

Characterization of therapeutic antibodies and related products.

Effect of the conserved oligosaccharides of recombinant monoclonal antibodies on the separation by protein A and protein G chromatography.

Quantification of immunoglobulin G and characterization of process related impurities using coupled protein A and size exclusion high performance liquid chromatography.

P304

487101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/487101

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27379284

http://www.w3.org/2001/XMLSchema#string

P932

4897240

http://www.w3.org/2001/XMLSchema#string

Development and Validation of an Affinity Chromatography-Protein G Method for IgG Quantification.

about

P2860

P2860

Development and Validation of an Affinity Chromatography-Protein G Method for IgG Quantification.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932